Aortic distensibility alterations in adults with m.3243A>G MELAS gene mutation

Attila Nemes1, Marcel L Geleijnse, Wim Sluiter

  • 1Department of Cardiology, Thorax Centre, Erasmus MC, Rotterdam, The Netherlands. nemes@in2nd.szote.u-szeged.hu

Swiss Medical Weekly
|February 24, 2009
PubMed
Abstract

Insights

Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) patients exhibit increased aortic stiffness and larger aortic dimensions. Gene carriers showed intermediate aortic elastic properties compared to patients and controls.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Neurology

Background:

  • Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a rare genetic disorder.
  • Vascular complications, particularly in the aorta, are increasingly recognized in MELAS.
  • This study investigates aortic elasticity in MELAS patients and gene carriers.

Purpose of the Study:

  • To assess ascending aortic elasticity in adult MELAS patients.
  • To evaluate aortic elastic properties in asymptomatic MELAS gene carriers.
  • To compare aortic dimensions and elasticity between MELAS patients, gene carriers, and healthy controls.

Main Methods:

  • Echocardiography was used to measure systolic and diastolic ascending aortic diameters.
  • Aortic elastic properties were calculated using aortic dimensions and forearm blood pressure.
  • Eight MELAS patients, four gene carriers, and age/gender-matched controls were included.

Main Results:

  • MELAS patients and gene carriers displayed enlarged ascending aortic diameters compared to controls.
  • Aortic stiffness index was significantly higher in MELAS patients (16.4±3.7) versus controls (3.6±1.1).
  • Aortic strain and distensibility were significantly reduced in MELAS patients compared to controls.

Conclusions:

  • MELAS syndrome is associated with increased ascending aortic stiffness.
  • Enlarged aortic dimensions suggest vascular remodeling in MELAS patients.
  • Gene carriers exhibit intermediate aortic elastic properties, indicating potential subclinical vascular changes.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...